“…Thus, among the larger studies reported recently, Reyniak et al (1980) found that about 30% of 123 subjects on oral contraceptives had 'hyperprolactinaemia', when hyperprolactinaemia was defined as any prolactin concentration above 20 ng/ml, a value presumably derived from the general population. On the other hand, when prolactin levels were compared to age-and sex-matched controls, as in the large cross-sectional studies of Davies et al Pansini et al (1983), no significant elevation of serum prolactin among patients taking oral contraceptives could be detected. Differences in the definition of hyperprolactinaemia, as well as in the oestrogen content of contraceptives employed and perhaps other factors, such as patient selection and time of blood sampling, probably account for the discrepant results among several other earlier studies (Abu-Fadil et al, 1976;Dericks-Tan et al, 1976;Spellacy et al, 1978).…”